Association of c-reactive protein with cardiovascular risk factors, lung function and quality of life in young adults

Authors

DOI:

https://doi.org/10.21527/2176-7114.2024.48.13889

Keywords:

Inflammation, Obesity, abdominal obesity, lung function test, quality of life

Abstract

Objective: To associate ultrasensitive C-reactive protein (US-CRP) with cardiovascular risk factors, lung function and quality of life. Methods: Body mass index (BMI), waist circumference (WC), haemodynamic parameters, blood sampling for US-CRP, spirometry (peak expiratory flow - PEF; forced expiratory volume in one second - FEV1) and individualised application of the Short Form-36 (SF-36) health-related quality of life (HRQoL) questionnaire. Results: Of the 100 young adults studied, BMI and WC were higher in those at high risk. PEF and FEV1/FVC ratio were higher in low-risk young adults. Mental health, functional capacity and vitality (VT) were higher in young people at lower cardiovascular risk. Of the overweight/obese young adults, 87.5% were at moderate and high risk (p=0.044), and of those with WC above the predicted level, 86.7% were at moderate and high risk (p=0.002). Among young adults with HRQoL above P(50), 43.5%, 50%, and 45.7% were at low cardiovascular risk for functional capacity, general health, and vitality, respectively. US-CRP was positively correlated with BMI (p=0.044), whereas PEF (p=0.046) and FEV1/FVC ratio (p=0.002) were inversely correlated. Conclusions: US-CRP was associated with BMI and WC, lung function and HRQoL, especially with respect to physical aspects. Obesity control should be emphasized, and regular physical activity and proper nutrition may help, including reducing the chronic inflammatory response.

References

Chooi YC, Ding C, and Magkos F. The epidemiology of obesity. Metabolism. 2019; 92: p. 6-10, Available from: https://www.sciencedirect.com/science/article/abs/pii/S002604951830194X.

Wang Y, Beydoun MA, Min J, Xue H, Kaminsky LA, and Cheskin LJ. Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic. Int J Epidemiol. 2020; 49(3): p. 810-823. DOI: 10.1093/ije/dyz273

Dalle Grave R, Soave F, Ruocco A, Dametti L, and Calugi S. Quality of Life and Physical Performance in Patients with Obesity: A Network Analysis. Nutrients. 2020; 12(3). DOI: 10.3390/nu12030602

Svartengren M, et al. The impact of body mass index, central obesity and physical activity on lung function: results of the EpiHealth study. ERJ Open Res. 2020; 6(4). DOI: 10.1183/23120541.00214-2020

Powell-Wiley TM, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021; 143(21): p. e984-e1010. DOI: 10.1161/cir.0000000000000973

Pavela G, Kim Y-i, and Salvy S-J. Additive effects of obesity and loneliness on C-reactive protein. PloS one. 2018; 13(11): p. e0206092. DOI: 10.1371/journal.pone.0206092

Saltiel AR and Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017; 127(1): p. 1-4. DOI: 10.1172/jci92035

Brock JM, Billeter A, Müller-Stich BP, and Herth F. Obesity and the Lung: What We Know Today. Respiration. 2020; 99(10): p. 856-866. DOI: 10.1159/000509735

Ishikawa C, Barbieri MA, Bettiol H, Bazo G, Ferraro AA, and Vianna EO. Comparison of body composition parameters in the study of the association between body composition and pulmonary function. BMC Pulm Med. 2021; 21(1): p. 178. DOI: 10.1186/s12890-021-01543-1

Jung DH, Shim JY, Ahn HY, Lee HR, Lee JH, and Lee YJ. Relationship of body composition and C-reactive protein with pulmonary function. Respir Med. 2010; 104(8): p. 1197-203. DOI: 10.1016/j.rmed.2010.02.014

World Health Organization. Diet, nutrition, and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. Vol. 916. 2003: World Health Organization.

World Health Organization. Waist Circumference and Waist–Hip Ratio. Report of a WHO Expert Consultation. Geneva, 8-11 December 2008. 2008(December): p. 8-11.

Barroso WKS, et al. Diretrizes Brasileiras de Hipertensão Arterial–2020. Arquivos Brasileiros de Cardiologia. 2021; 116: p. 516-658. DOI: 10.36660/abc.20201238

Ridker PM. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation. 2003; 108(12): p. e81-5. DOI: 10.1161/01.cir.0000093381.57779.67

Graham BL, et al. Standardization of spirometry 2019 update. An official American thoracic Society and European respiratory Society technical statement. American journal of respiratory and critical care medicine. 2019; 200(8): p. e70-e88. DOI: 10.1164/rccm.201908-1590ST

Neder JA, Andreoni S, Castelo-Filho A, and Nery LE. Reference values for lung function tests. I. Static volumes. Braz J Med Biol Res. 1999; 32(6): p. 703-17. DOI: 10.1590/s0100-879x1999000600006

Ciconelli RM, Ferraz MB, Santos W, Meinao IM, and Quaresma MR. Tradução para a lingua portuguesa e vaidação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Revista Brasileira de Reumatologia. 1999; 39(3): p. 143-150. https://pesquisa.bvsalud.org/portal/resource/pt/lil-296502

Cercato C and Fonseca FA. Cardiovascular risk and obesity. Diabetology & Metabolic Syndrome. 2019; 11(1): p. 74. Available from: https://doi.org/10.1186/s13098-019-0468-0

Menezes CA, Costa GLOB, Barreto RF, and Oliveira VS. Proteína C reativa importante biomarcador de risco cardiometabólico na obesidade infanto-juvenil. Saúde Coletiva (Barueri). 2021; 11(65): p. 5882-5895. https://doi.org/10.36489/saudecoletiva.2021v11i65p5882-5895

Landecho MF, Tuero C, Valentí V, Bilbao I, de la Higuera M, and Frühbeck G. Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk. Nutrients. 2019; 11(11): p. 2664. DOI: 10.3390/nu11112664

Rasmussen F, et al. High-sensitive C-reactive protein is associated with reduced lung function in young adults. Eur Respir J. 2009; 33(2): p. 382-8. DOI: 10.1183/09031936.00040708

Nybo M, Hansen HS, Siersted HC, and Rasmussen F. No relationship between lung function and high‐sensitive C‐reactive protein in adolescence. The Clinical Respiratory Journal. 2010; 4(4): p. 230-236. DOI: 10.1111/j.1752-699X.2009.00181.x

Ahmadi-Abhari S, Kaptoge S, Luben RN, Wareham NJ, and Khaw KT. Longitudinal association of C-reactive protein and lung function over 13 years: The EPIC-Norfolk study. Am J Epidemiol. 2014; 179(1): p. 48-56. DOI: 10.1093/aje/kwt208

Cho HJ, Seeman TE, Bower JE, Kiefe CI, and Irwin MR. Prospective association between C-reactive protein and fatigue in the coronary artery risk development in young adults study. Biol Psychiatry. 2009; 66(9): p. 871-8. DOI: 10.1016/j.biopsych.2009.06.008

Black PH. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun. 2002; 16(6): p. 622-53. DOI: 10.1016/s0889-1591(02)00021-1

Published

2024-05-14

How to Cite

Bueno, N. S. ., Silva, P. H. de A., Gomes, A. J. R. ., Carvalho, C. S. ., Moreira, E. M. L. ., Oliveira, S. R. R. ., & Soares, V. (2024). Association of c-reactive protein with cardiovascular risk factors, lung function and quality of life in young adults. Revista Contexto &Amp; Saúde, 24(48), e13889. https://doi.org/10.21527/2176-7114.2024.48.13889

Issue

Section

ORIGINAL ARTICLE